Nike (NKE) Given a $72.00 Price Target by Macquarie Analysts

Nike (NKE) Given a $72.00 Price Target by Macquarie Analysts

Nike (NKE) Given a $72.00 Price Target by Macquarie Analysts

Among active positions in the latest quarter, 531 holders increased their positions by a total of 56.64 million shares, 685 holders decreased the positions by a total of 64.75 million shares, and 167 holders held their positions. About 128,324 shares traded. Tahoe Resources Inc. (NYSE:TAHO) has declined 23.51% since January 10, 2017 and is downtrending. It has underperformed by 1.13% the S&P500.

Eventide Asset Management Llc increased its stake in Snap On Inc (SNA) by 2.19% based on its latest 2017Q3 regulatory filing with the SEC.

Shares of Nike Inc (NYSE:NKE) traded down $0.03 during midday trading on Wednesday, hitting $64.06. Volatility this month is 1.78%, which compared to the average volume of 10,106.09 can give you an idea of the movements of the company's stock. Canaccord Genuity maintained NIKE, Inc. Capital World Investors now owns 21,779,409 shares of the footwear maker's stock valued at $1,284,985,000 after purchasing an additional 8,058,601 shares during the last quarter. Looking at the other side of the coin, NKE traded as low as $50.35 in the past 52 weeks, and since then the shares have risen 27.29% or $13.74. It is down 0.00% since January 10, 2017 and is. It has underperformed by 25.94% the S&P500.

Investors sentiment decreased to 0.8 in Q3 2017.

The company's stock is now moving with a +ve distance from the 200 day SMA of approximately 14.51%, and has a solid year to date (YTD) performance of 2.78% which means that the stock is constantly adding to its value from the previous fiscal year end price. It is negative, as 87 investors sold NKE shares while 457 reduced holdings.

Health Alert: FDA warns of opioids in cold medicines
The FDA says treating sick children with medicines that contain opioids poses "serious risks that don't justify their use". Common side effects of opioid use include headache, vomiting, dizziness, breathing difficulties and even death.

Several other hedge funds and other institutional investors have also recently made changes to their positions in NKE. The footwear maker reported $0.46 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.40 by $0.06. Bancorpsouth holds 0.03% or 5,129 shares in its portfolio. Checchi Advisers Limited Com reported 0.06% of its portfolio in NIKE, Inc. (NYSE:NKE) is 1.23287. (NYSE:NKE). Cypress Mngmt Ltd Liability (Wy) reported 0.72% in NIKE, Inc. Janus Henderson Group PLC now owns 16,619,387 shares of the footwear maker's stock valued at $980,539,000 after buying an additional 16,237,557 shares in the last quarter. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv has invested 0.04% in EVERTEC, Inc. (NYSE:NKE). Genesee Valley Tru Commerce holds 39,859 shares. State Of Tennessee Treasury Department holds 0.23% of its portfolio in NIKE, Inc. Capital World Investors grew its position in Nike by 58.7% during the 2nd quarter. (NYSE:NKE). Moreover, Glg Prtn LP has 0.14% invested in NIKE, Inc. Segall Bryant & Hamill accumulated 218,133 shares or 0.26% of the stock. Eaton Vance Mgmt accumulated 5.25 million shares. Short interest, which represents the number of a stock's shares now being shorted, captures what the market as a whole feels about a stock.

NIKE, Inc. (NYSE:NKE) has a current MF Rank of 4873. Three research analysts have rated the stock with a sell rating, twenty have issued a hold rating and twenty-one have issued a buy rating to the stock. Therefore 52% are positive. The Price Range of NIKE, Inc. The stock has "Buy" rating by S&P Research on Monday, September 28. (NYSE:NKE) rating on Tuesday, April 11. With that said, researchers took a deep dive into the hotly debated question: is it too late to buy NIKE, Inc. The firm has "Outperform" rating by Credit Suisse given on Wednesday, March 23. On Friday, August 14 the stock rating was maintained by JP Morgan with "Neutral". (NYSE:NKE) can provide us with excellent insight into how the company's stock is performing. (NYSE:NKE) has "Buy" rating given on Wednesday, June 29 by UBS. Vetr raised shares of Nike from a sell rating to a hold rating and set a $63.22 price objective for the company in a research report on Monday, January 1st. Oppenheimer maintained Snap-on Incorporated (NYSE:SNA) on Tuesday, May 30 with "Buy" rating.

Since September 14, 2017, it had 0 insider buys, and 6 sales for $23.60 million activity. Juliana B. Marriott Marital Trust sold $3.00 million worth of stock or 30,000 shares. RODGERS JOHNATHAN A had sold 16,000 shares worth $855,206. Exane Derivatives owns 35,687 shares. Bank & Trust Of Nova Scotia Trust Company stated it has 0.42% in NIKE, Inc.

Investors sentiment increased to 1.35 in 2017 Q3. Its down 0.20, from 1 in 2017Q2. Its up 10.11% from 7.14 million shares previously. 58 funds opened positions while 196 raised stakes. Amalgamated Fincl Bank stated it has 0.07% in Gartner, Inc. (NASDAQ:FELE). Channing Cap Mgmt Ltd Limited Liability Company holds 1.16% or 688,705 shares in its portfolio. Following the completion of the transaction, the chairman now owns 1,637,736 shares in the company, valued at $90,124,612.08. Nomura Hldg reported 0% of its portfolio in Gartner, Inc. 2,094 are held by Regentatlantic Cap Ltd. California-based Nelson Roberts Invest Advsr has invested 0% in Marriott International, Inc. Menta Capital Llc, a California-based fund reported 490,127 shares. (NYSE:NKE). Illinois-based Rothschild Corp Il has invested 0.09% in NIKE, Inc. Reilly Advisors Ltd Liability Corp holds 0% or 24 shares in its portfolio. (NASDAQ:MAR) for 3,601 shares.

Among 7 analysts covering Evertec (NYSE:EVTC), 1 have Buy rating, 1 Sell and 5 Hold. Therefore 69% are positive. The rating was maintained by Stifel Nicolaus on Wednesday, November 8 with "Hold". The stock of Gartner, Inc. (TSE:SJ) has "Outperform" rating given on Thursday, February 4 by RBC Capital Markets. The rating was initiated by CLSA with "Underperform" on Thursday, January 19. The firm has "Overweight" rating given on Monday, March 21 by JP Morgan. The firm earned "Neutral" rating on Wednesday, June 1 by Bank of America.

Latest News